Medical scientists in Minnesota are focusing their expertise on a pest that destroys soybeans. The goal of the Minnesota Partnership team is to develop an insecticide that is safe for humans but will kill the soybean aphid, a bug that's been ravaging Minnesota crops. Their findings appear in the journal Public Library of Science -- PLoS One.
"We've shown in the laboratory that we're 99 percent effective in inhibiting a key enzyme in two aphids, one that damages soybeans," says Stephen Brimijoin, Ph.D., a Mayo Clinic researcher on the team. "This means we should be able to stop the insect without harming other animals or humans because the target we're hitting is selective to the aphid."
Dr. Brimijoin collected soybean aphids from demonstration plots at the University of Minnesota Extension facility in Rochester and isolated the key enzyme in the aphids, while Yuan-Ping Pang, Ph.D., Mayo Clinic co-investigator, characterized the molecular structures of the target area.
"We're reporting the development of a small molecule that blocks nearly all acetylcholinesterase (AChE) activity in the greenbug and the soybean aphid, but without inhibiting AChE in humans," says Dr. Pang. "Now we need to see how well that translates to the field." Overseeing that phase will be David Ragsdale, Ph.D., an entomologist at the University of Minnesota and another co-investigator. The researchers estimate that phase of the project will begin in a few weeks.
"Our organization is excited about this project and closely awaiting the outcome," says Gene Stoel, research chair, Minnesota Soybean Research and Promotion Council. "This is a great example of how Minnesota's medical and agriculture sectors can work together for everyone."
Currently, no insecticide can counter the soybean aphid, according to Dr. Brimijoin. Various aphid species adapt to organophosphate insecticides and those chemicals can often prove toxic to birds and humans. Instead of targeting serine, as has been the case for decades, the small molecule developed by Dr. Pang focuses on a novel cystine target called Cys289, to which aphids and other insects cannot develop a resistance. Only 6 micromoles in size, the molecule caused "irreversible inhibition" in the greenbug. It had the same impact on the soybean aphid, though that data was too recent to include in the article.
The Minnesota Partnership for Biotechnology and Medical Genomics has been funding research aimed at disease for five years. The soybean aphid research shows the broader benefits of modern genomic and molecular science in Minnesota's top medical research institutions. It also demonstrates an expansion from treating or curing patients to preventing diseases through proactively improving environmental health.
Robert Nellis | EurekAlert!
Plasma-zapping process could yield trans fat-free soybean oil product
02.12.2016 | Purdue University
New findings about the deformed wing virus, a major factor in honey bee colony mortality
11.11.2016 | Veterinärmedizinische Universität Wien
Yersiniae cause severe intestinal infections. Studies using Yersinia pseudotuberculosis as a model organism aim to elucidate the infection mechanisms of these...
Researchers from the University of Hamburg in Germany, in collaboration with colleagues from the University of Aarhus in Denmark, have synthesized a new superconducting material by growing a few layers of an antiferromagnetic transition-metal chalcogenide on a bismuth-based topological insulator, both being non-superconducting materials.
While superconductivity and magnetism are generally believed to be mutually exclusive, surprisingly, in this new material, superconducting correlations...
Laser-driving of semimetals allows creating novel quasiparticle states within condensed matter systems and switching between different states on ultrafast time scales
Studying properties of fundamental particles in condensed matter systems is a promising approach to quantum field theory. Quasiparticles offer the opportunity...
Among the general public, solar thermal energy is currently associated with dark blue, rectangular collectors on building roofs. Technologies are needed for aesthetically high quality architecture which offer the architect more room for manoeuvre when it comes to low- and plus-energy buildings. With the “ArKol” project, researchers at Fraunhofer ISE together with partners are currently developing two façade collectors for solar thermal energy generation, which permit a high degree of design flexibility: a strip collector for opaque façade sections and a solar thermal blind for transparent sections. The current state of the two developments will be presented at the BAU 2017 trade fair.
As part of the “ArKol – development of architecturally highly integrated façade collectors with heat pipes” project, Fraunhofer ISE together with its partners...
At TU Wien, an alternative for resource intensive formwork for the construction of concrete domes was developed. It is now used in a test dome for the Austrian Federal Railways Infrastructure (ÖBB Infrastruktur).
Concrete shells are efficient structures, but not very resource efficient. The formwork for the construction of concrete domes alone requires a high amount of...
10.01.2017 | Event News
09.01.2017 | Event News
05.01.2017 | Event News
18.01.2017 | Power and Electrical Engineering
18.01.2017 | Materials Sciences
18.01.2017 | Life Sciences